Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inRegen”

4 pharma patents match "inRegen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "inRegen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “inRegen” · 30,257 patents in full index Clear search

  1. US 11066666

    Bioactive renal cells

    inRegen · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  2. US 10363274

    Renal cell populations and uses thereof

    inRegen · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  3. US 10105392

    Isolated renal cells and uses thereof

    inRegen · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  4. US 10077442

    Bioactive renal cells

    inRegen · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.